HNC-23125-73018
4 vaccinations
6 coded responses
31 check-ins
6 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 750 / TX
- Registered
- 2021-03-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
FDD-27824-37731
Child or adolescent in my care · Female · 2022-10-07
UNA-67889-16070
Child or adolescent in my care · Male · 2022-10-07
Timeline
-
2021-02-13
Dose 1 — Pfizer-BioNTech
-
2021-03-09
Registered in v-safe
-
2021-03-09
Dose 2 — Pfizer-BioNTech
-
2021-03-09
Survey response — day 0, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain, Redness · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: DizzyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Itching · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-11
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain — Feeling: Fair · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Pain in armpit areaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fever · Chills, Fatigue or tirednessAdult check-in
-
2021-03-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-14
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, NauseaAdult check-in
-
2021-03-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-03-16
- 2021-03-23
- 2021-03-30
- 2021-04-07
- 2021-04-13
- 2021-04-20
-
2021-06-08
Survey response — 3 months, dose 2MedDRA: Abortion spontaneous, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Miscarriage at around 6.5 weeks along 3 weeks ago. · Healthcare visit (other): In office visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-08
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-10
-
2021-09-07
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: Pregnant and due 3/17/22MedDRA releases: 2024-11 · check-in free text available
-
2021-10-11
Dose 3 — Pfizer-BioNTech
-
2022-03-09
Survey response — 12 months, dose 2MedDRA: COVID-19, Pregnancy, SARS-CoV-2 test negative, SARS-CoV-2 test positive, Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: Had covid while 33 weeks pregnant. Tested negative roughly 2 weeks after testing positive. · Healthcare visit (other): Additional ultrasoundsMedDRA releases: 2024-11 · check-in free text available
-
2022-03-09
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2022-03-11
- 2022-04-11
- 2022-10-11
-
2022-11-01
Dose 4 — Pfizer-BioNTech
-
2022-11-03
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-11-04
-
2022-11-05
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Chills, Fatigue or tirednessAdult check-in
- 2022-11-06
- 2022-11-07
- 2022-11-08
- 2022-11-17
-
2022-11-23
Survey response — day 21, dose 4MedDRA: Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Runny nose and congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-12-01
- 2022-12-06
- 2022-12-14
- 2023-01-31
- 2023-05-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-13 | Pfizer-BioNTech | |
| 2 | 2021-03-09 | Pfizer-BioNTech | |
| 3 | 2021-10-11 | Pfizer-BioNTech | No |
| 4 | 2022-11-01 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-08 | Unsuccessful | |
| 2022-03-09 | Unsuccessful |
Free text
Release 5 — day 0, dose 2
Systemic reaction (other): Dizzy
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Pain in armpit area
Release 8 — 3 months, dose 2
Symptoms: Miscarriage at around 6.5 weeks along 3 weeks ago.
Healthcare visit (other): In office visit
Release 9 — 6 months, dose 2
Symptoms: Pregnant and due 3/17/22
Release 11 — 12 months, dose 2
Symptoms: Had covid while 33 weeks pregnant. Tested negative roughly 2 weeks after testing positive.
Healthcare visit (other): Additional ultrasounds
Release 12 — day 21, dose 4
Symptoms: Runny nose and congestion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Abortion spontaneous | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release